Skip to main content
ASPHO Logo
Menu Journal My Account Contact Join/Renew
Login
  • Meetings & Events
    • Conference
      • 2027 Conference
      • 2027 Call for Workshops
      • Press | 2018 Conference
      • 2018 Call for Papers and Posters
        • Back to Meetings
        • Registration Rates
        • Conference Planning Committee
        • Faculty
        • 2019 Call for Papers and Posters
        • PBMTC
        • Accepted Papers and Posters
        • MOC Opportunities
        • App - Thank you for Attending
        • Annual Meeting Brochure
        • Virtual Bag
        • Schedule of Events
        • Attendee List
        • 2017 Searchable Abstract Database
        • Accepted Papers and Posters
        • Corporate Forum Symposia/Education Theater
        • Travel
        • Program Committee
        • Commercial Support
        • Exhibit with ASPHO
      • Commercial Support
      • Meetings Archive
      • Registration Information
      • Conference Policies
      • 2027 Call for Papers and Posters
    • FDA/ASPHO Educational Program
    • Review Course
      • Anderson 2019
      • McClain 2019
      • Adams 2019
      • Moran 2019
      • Effinger 2019
      • Fangusaro 2021
      • Brown 2021
      • Young 2021
      • Harker-Murray 2021
      • Effinger 2021
      • Pai 2021
      • Grace 2021
      • Rogers 2021
      • Anderson 2021
      • Powers 2021
      • McClain 2021
      • Neunert 2021
      • Fleming 2021
      • Mullen 2021
      • Pommert 2021
      • Meade 2021
      • Greengard 2021
      • Fox 2021
      • Bercovitz 2021
      • Brock 2021
      • Adams 2021
      • Loh 2021
      • O'Brien 2021
      • Walterhouse 2021
      • Pulsipher 2021
      • Oberley 2021
      • Rodriguez-Galindo 2021
      • Kesselheim 2021
      • Frei-Jones 2021
      • Allen 2021
      • 2015 Online Review Course CME Certificates
      • 2019 Planning Committee
      • 2019 Schedule
      • 2019 Travel
      • 2019 Review Course Early Career
      • 2019 Review Course Directors
        • 2019 Review Course Faculty
      • Oberley 2019
      • O'Brien 2019
      • Pai 2019
      • Pulsipher 2019
      • Rodriguez-Galindo 2019
      • Rogers 2019
      • Walterhouse 2019
      • Young 2019
      • Park 2019
      • Malec 2019
      • Evaluations
      • Brown 2019
      • Allen 2019
      • Fangusaro 2019
      • Fleming 2019
      • Frei-Jones 2019
      • Grace 2019
      • Harker-Murray 2019
      • Heeney 2019
      • Kesselheim 2019
      • Loh 2019
      • Mascarenhas 2019
      • Neunert 2019
      • Fangusaro 2023
      • Adams 2023
      • Neunert 2023
      • Oberley 2023
      • Grace 2023
      • Effinger 2023
      • Nakano 2023
      • Brock 2023
      • Harker-Murray 2023
      • Meade 2023
      • Fleming 2023
      • Kesselheim
      • Kumar 2023
      • Anderson 2023
      • Malogolowkin 2023
      • Pommert 2023
      • Bercovitz 2023
      • Frei-Jones 2023
      • O'Brien 2023
      • Pai 2023
      • Young 2023
      • Fox 2023
      • Powers 2023
      • Pulsipher 2023
      • McClain 2023
      • Loh 2023
      • Greengard 2023
      • Frazier 2023
      • Brennan 2023
      • Walkovich 2023
      • Browning 2023
      • Mullen 2023
        • 2025 Faculty
        • 2025 Schedule
        • 2025 Cancellation Policies and Disclosures
        • 2025 Planning Committee
        • Young 2025
        • Bercovitz 2025
        • Brennan 2025
        • Fangusaro 2025
        • Fox 2025
        • Frazier 2025
        • Greengard 2025
        • O'Brien 2025
        • Pommert 2025
        • Powers 2025
        • Pulsipher 2025
        • Walkovich 2025
        • Neunert 2025
        • Adams 2025
        • Oberley 2025
        • Grace 2025
        • Effinger 2025
        • Nakano 2025
        • Brock 2025
        • Harker-Murray 2025
        • Meade 2025
        • Fleming 2025
        • Kesselheim 2025
        • Kumar 2025
        • Creary 2025
        • DeNardo 2025
        • Dome 2025
        • Jordan 2025
        • McCavit 2025
        • Pai 2025
        • Raetz 2025
        • Malogolowkin 2025
        • Terrell 2025
        • Kucine 2025
    • Events Calendar
    • Online Review Course
    • October 2015 Enews
    • Advocacy Sample
    • 2017 Workforce Survey Report
    • Help Fund the STAT Act
  • PRODUCTS & RESOURCES
    • Products
      • KARE Toolkit: Knowledge and Assessment Resources
        • CME for KARE
        • CME for RC On-Demand
        • CME for PHO Review Course On Demand
        • CME for KARE Plus
        • CME for KARE Plus Hematology
        • CME for KARE Plus Oncology
        • The KARE Toolkit - Index of Topics
      • Webinars
      • ASPHOcast
      • Alexion Recording
      • 2024 Compensation Survey
      • Webinar Toolkit
      • Compensation and Benefits Report
      • View the Compensation and Benefits Survey Report
      • Compensation Tool
      • Case Quizzes
    • Pediatric Blood & Cancer
      • Access Journal
      • Online Access Instructions
    • ASPHO eNews
      • August 2015 Enews
      • June 2015 Enews
      • April 2015 Enews
      • February 2015 Enews
      • December 2014 Enews
      • October 2014 Enews
      • August 2014 Enews
      • June 2014 Enews
      • April 2014 Enews
      • February 2014 Enews
      • December 2013 Enews
      • October 2013 Enews
      • August 2013 Enews
      • June 2013 Enews
      • April 2013 Enews
      • February 2013 Enews
      • October 2014 Enews
      • October 2015 Enews
      • December 2015 Enews
      • February 2016 Enews
      • April 2016 Enews
      • June 2016 Enews
        • DSIG Student Registration
      • August 2016 Enews
      • October 2016 Enews
      • December 2016 Enews
      • February 2017 Enews
      • April 2017 Enews
      • June 2017 Enews
      • August 2017 Enews
      • October 2017 Enews
      • December 2017 Enews
      • February 2018 Enews
      • April 2018 Enews
      • June 2018 Enews
      • August 2018 eNews
      • October 2018 eNews
      • February 2019 eNews
      • Member Insights: eNews 2018 Highlights
      • April 2019 eNews
      • June 2019 eNews
      • August 2019 eNews
      • October 2019 eNews
      • December 2019 eNews
      • February 2020 eNews
      • April 2020 eNews
      • June 2020 eNews
      • August 2020 eNews
      • October 2020 eNews
      • December 2020 eNews
      • April 2021 eNews
      • June 2021 eNews
      • August 2021 eNews
        • August 2021 President's Message
      • December 2021 eNews
      • February 2022 eNews
      • April 2022 eNews
      • June 2022 eNews
      • August 2022 eNews
      • October 2022 eNews
      • December 2022 eNews
      • February 2023 eNews
      • April 2023 eNews
      • June 2023 eNews
      • October 2023 eNews
      • December 2023 eNews
      • February 2024 eNews
      • March 2024 eNews
      • April 2024 eNews
      • June 2024 eNews
      • August 2024 eNews
      • October 2024 eNews
      • December 2024 eNews
      • February 2025 eNews
      • April 2025 eNews
      • June 2025 eNews
      • August 2025 eNews
      • October 2025 eNews
      • December 2025 eNews
      • February 2026 eNews
      • April 2026 eNews
      • June 2026 eNews
      • August 2026 eNews
    • Pediatric Blood & Cancer - Call for Applications for Deputy Editor
    • Practice and Quality
      • Choosing Wisely®
      • Position Paper
      • Endorsements
      • ASPHO Endorsements member only
    • Health Policy & Advocacy
      • 2016 August Advocacy Brief
      • 2016 December Advocacy Brief
      • 2017 February Advocacy Brief
      • 2017 May Advocacy Brief
      • 2017 September Advocacy Brief
      • 2017 November Advocacy Brief
      • 2018 Advocacy Brief - March
      • Contact Your Members of Congress
      • 2018-Advocacy-Brief-June
      • 2018-Advocacy-Brief-September
      • Advocacy Brief December 2018
      • 2019 Advocacy Brief - March
      • March 2019 Advocacy Brief
      • June 2019 Advocacy Brief
      • September 2019 Advocacy Brief
      • March 2020 Advocacy Brief
      • June 2020 Advocacy Brief
      • September 2020 Advocacy Brief
      • December 2020 Advocacy Brief
      • June 2021 Advocacy Brief
      • September 2021 Advocacy Brief
      • March 2022 Advocacy Brief
      • June 2022 Advocacy Brief
      • September 2022 Advocacy Brief
      • March 2024 Advocacy Brief
      • September 2024 Advocacy Brief
      • December 2024 Advocacy Brief
      • March 2025 Advocacy Brief
      • 2025 September Advocacy Brief
      • December 2025 Advocacy Brief
      • March 2026 Advocacy Brief
      • June 2026 Advocacy Brief
    • News Briefs
  • Career Development
    • Mentoring
      • Enroll as a Mentee
      • Enroll as a Mentor
      • Early Career Mentoring
      • Individualized Career Development Program
      • Mentors for Physicians
    • Awards
      • Distinguished Career Award
      • Oski Memorial Research Lectureship
      • International Travel Awards
      • Buchanan Lectureship
      • Young Investigator Award
      • Young Investigator Form
      • EC Travel Stipend Form
      • Early Career Travel Awards
      • Advanced Practice Provider Award
      • Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
    • Career Center
      • Virtual Career Fair
    • Fellowship Resources
      • Post-PHO Fellowship Program Directory
      • Fellowship Program Directors' Resources
    • Certification
      • Continuing Medical Education
      • advocating for moc
      • ABP MOC Letter Nov 2015
      • ABP Hematology/Oncology Content Outline
    • 2019 ASPHO Award Recipients
    • Workforce
  • Membership
    • Who Belongs
    • Benefits
    • Join Us
    • Renew
    • Membership Application
    • Fellows Group Application
    • Member Community
    • Find a Member
    • Special Interest Groups
      • Adolescent and Young Adult SIG
      • Advanced Practice Provider SIG
      • Cancer Predisposition SIG
      • Clinical Immunology SIG
      • Diversity SIG
        • 2017 DSIG Travel Award
      • Global Hem Onc SIG
      • Hemoglobinopathy SIG
      • Hospitalist Medicine SIG
      • Informatics, Innovation and Entrepreneurship SIG
      • Integrative Pediatric Hematology/Oncology SIG
      • Palliative Care SIG
      • Physician Scientist SIG
      • Quality Improvement and Patient Safety SIG
      • Small Program SIG
      • Vascular Anomalies SIG
      • Clinical Immunology SIG Webinar
      • Well-Being SIG
    • Enriching the Future
      • ETF Donors
      • ETF FAQ
      • ETF Programs
      • ETF Award Recipients
      • Donate
    • Stay Connected with ASPHO
    • New Member
    • Trainee Membership Level
    • Strengthen Your Everyday Practice
    • Member Engagement
  • About
    • Governance
      • 2017 Election Nominations
      • 2019 Board and Nominating Committee members
      • Board of Trustees
      • Leadership Development & Election Process
      • Nominating FAQs
      • Strategic Plan
        • Leadership Domain
        • Education Domain
        • Career Domain
        • Administration Domain
      • Volunteer Opportunities
        • Early Career Council
      • Social Media Ambassador Volunteer Opportunity
    • Policies
      • Advertising Sponsorship
      • Support of CME
      • Committee Policies, Responsibilities, and Resources
      • Conflict of Interest and Disclosure for Volunteers
      • Distinguished Career Award Eligibility Criteria
      • Diversity Statement
      • Investment
      • Member Mailing List
      • Oski Eligibility Criteria
      • Presidential Stipend
      • Records Retention
      • Reserve Fund
      • Reviews and Endorsements
      • Speaker Reimbursement
      • Surveying Members
      • Whistleblower
      • Workshop Session
      • Young Investigator Award
      • Early Career Travel Awards
      • Buchanan Lectureship Eligibility
      • ASPHO Statements
    • Terms of Use
    • Contact Us
    • 2016 Election Nominations
    • 2015 Election Candidates
    • FDA Approves Dinutuximab
    • Q&A Amy Billett
    • Fund Raising Policy
    • Partner with ASPHO
      • ASPHO Conference
      • Year-Round Exposure
      • Industry Relations Council
      • Grants
    • Diversity & Inclusion
    • Donate
    • DEI Member Perspectives
    • Account Access
    • Maintenance Message
  • 2017 Annual Meeting Session Recordings
  • 2018 Annual Meeting Session Recordings
  • George R. Buchanan Lectureship Award Presentation
  • Cancer Predispositions in Clinical Practice
  • Evidence and Equipoise in Pediatric Thrombosis - Updates from Randomized Controlled Trials
  • Playing on Our Strengths - Developing Interprofessional Teams in Pediatric Hematology-Oncology
  • Providing Optimal Pediatric Palliative Care: Overcoming the Barriers
  • When in Quebec, Do What the Quebecers Do (Part Deux) - It's All About Platelets!
  • Allogeneic Hematopoietic Stem Cell Transplantation (SCT) for Pediatric Patients with ALL in the era of Tyrosine Kinase Inhibitors, Novel Immunotherapies and 'MRD Status'
  • Award Presentations
  • Hemophilic Arthropathy, More Than Meets the Eye: Advances in Early Disease Detection from Clinical Tools to Musculoskeletal Imaging
  • ZFNs, CrispR/Cas9 and TALENS- Oh My!
  • Collaboration in the Treatment of Liver Tumors
  • Leukemia
  • Solid Tumors/Lymphoma
  • Hematology I
  • Beyond Antibodies and CAR T Cells: Challenges and Opportunities in Manipulating the Pediatric Cancer Immunome
  • Blood Clots in Sick Kids: A critical mini-review of venous thrombo-embolism in selected high-risk pediatric populations
  • It's not just about Diversity: Improving the Outcomes for All by Moving toward Equity
  • Children's Oncology Group (COG)
  • Outcomes Research
  • Social Media: The Good, The Bad, and Beyond
  • Sickle Cell Disease in the AYA population: Management Challenges for the Pediatric Hematologist
  • Molecularly Defined Rare Pediatric Sarcomas: An Update for the General Oncologist
  • Mechanisms of Tumor Microenvironment Immune Mediated Resistance and Methods of Therapeutic Circumvention
  • Behind the Scenes at Pediatric Blood & Cancer: Everything You Always Wanted to Know About Getting Published
  • New Insights in Inherited Hematologic Diseases
  • Changing Workforce of Pediatric Hematology/Oncology
  • New Diagnostic and Therapeutic Approaches of Opportunistic (Viral/Fungal) Infections in the Pediatric Cancer Patient
  • New Mutations and Targeted Therapies in Langerhans Cell Histiocytosis
  • Physician, Sustain Thyself: Building Resilience to Prevent Burnout
  • Practicing Precision in Pediatric Oncology: Three Perspectives
  • What's Happening in DC? A Look at ASPHO Advocacy Efforts
  • Critical Care of the Immunocompromised Pediatric Hematology/Oncology Patient
  • Brain Tumors
  • Hematology II
  • Partner with ASPHO
    • Exhibits
    • Advertising
    • Industry Relations Council
    • Exhibits Adveritising
  • Ward Testing OSE
  • 2018 Session | George R. Buchanan Lectureship Award Presentation
  • 2018 Session | Plenary Paper Session 2001-2002
  • 2018 Session | St. Baldrick's Foundation Robert J. Arceci Innovation Award Announcement
  • 2018 Session | Plenary Session—Health Care in the Current Political Climate: Stormy Days Ahead?
  • 2018 Session | Pediatric Ependymoma: The Science Driving Patient Care
  • 2018 Session | Iron: Let's Get Pumped
  • 2018 Session | Extracellular Vesicle Trafficking—Biology and Translational Impact in Hematology and Cancer
  • 2018 Session | Relapsed, Refractory, Metastatic Bone Sarcomas: New Insights on Pathogenesis, Prognosis and Treatment
  • 2018 Session | Alpha Thalassemia—A Growing Public Health Disease with Changing Landscape of In-Utero and Post-Natal Therapy
  • 2018 Session | Decision Making in Benign Hematology: Living in a World Without Randomized Trials
  • 2018 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
  • 2018 Session | Early Career Travel Stipend Awards
  • 2018 Session | Young Investigator Award Presentations
  • 2018 Session | Management of Extracranial Germ Cell Tumors in Adolescent and Young Adult Population
  • 2018 Session | Challenging Hematologic Complications Post–Stem Cell Transplantation and Beyond
  • 2018 Session | Advanced Symptom Management and End-of-Life Care: Multidisciplinary Primary Palliative Care for Pediatric Hematologists/Oncologists
  • 2018 Session | Paper Session - Solid Tumor
  • 2018 Session | Paper Session - Hematology
  • 2018 Session | Vascular Anomalies: The Great Mimickers
  • 2018 Session | Addressing Sexual Health in Adolescent and Young Adult Patients: What You Should Know as a Pediatric Hematology/Oncology Care Provider
  • 2018 Session | Navigating Intravascular Bottlenecks: A Critical Mini-Review of Pediatric Venous Thromboembolism in the Setting of an Anatomical Thrombophilia
  • 2018 Session | Paper Session - Children's Oncology Group (COG)
  • 2018 Session | Paper Session - Hematology Science
  • 2018 Session | Can Late Effects be Prevented in Pediatric Oncology?
  • 2018 Session | Clash of the Titans: Debates on Best Management of Patients with Bleeding Disorders
  • 2018 Session | Providing Effective Feedback: The Currency of Conflict Resolution
  • 2018 Session | Recent Advances and New Approaches to Rare Hematological Malignancies
  • 2018 Session | Primary and Secondary Stroke Prevention in Sickle Cell Disease: The Debate
  • 2018 Session | Combating an Unmet Need: Psychosocial Health
  • 2018 Session | Renal Tumors Beyond Wilms
  • 2018 Session | Pediatric and Neonatal Transfusion Medicine
  • 2018 Session | Mobile Applications in Clinical Practice
  • 2018 Session | Presidential Symposium—Partnering with Patients and Families to Improve Research and Clinical Decision-making
  • 2018 Session | Review of Rare Pediatric Head and Neck Tumors for the General Oncologist
  • 2018 Session | Emerging Therapies in Hemophilia
  • 2018 Session | How Should You Treat That Bug? A Debate About Antimicrobial Management in Fever and Neutropenia
  • 2018 Session | Paper Session with Luminary Investigator - Leukemia
  • 2018 Session | Paper Session with Luminary Investigator - Hematology
  • 2018 Session | Frank A. Oski Memorial Lectureship Award Presentation
  • December 2018 eNews
  • 2019 Session | Splenectomy - The Great Debate
  • 2019 Session | DICER1: Updates on Biology and Clinical Management
  • 2019 Session | Burnout in Pediatric Hematology/Oncology: Moving from Discussion to Action
  • 2019 Session | Diagnostic and Management Conundrums Surrounding Women with Heavy Menstrual Bleeding and Underlying Bleeding Disorders
  • 2019 Session | All That Glitters is Not Gold – How We Differentiate Primary HLH from Fake News
  • Models for International Pediatric Oncology Outreach
  • 2019 Session | Navigating Genetic Testing in the Pediatric Hematology Setting
  • 2019 Session | Radiation Therapy for Pediatric Cancer Patients: Updates and New Modalities
  • 2019 Session | The Microbiome: What Is It and Why Do We Care?
  • 2019 Session | Brain Attack: Therapeutic Advances in Neonatal and Childhood Stroke
  • 2019 Session | Advances in Pediatric AML
  • 2019 Session | Improving Medication Adherence for Adolescents and Young Adults: Is Technology the Answer?
  • 2019 Session | Metabolism in Pediatric Hematology/Oncology - Presidential Symposium
  • 2019 Session | Too Much of a Good Thing – Myeloproliferation in Children
  • 2019 Session | Multiple Bony Lytic Lesions, but Not Langerhans Cell Histiocytosis (LCH) – Now What?
  • 2019 Session | Savior Siblings: Medical, Ethical, and Psychosocial Considerations in using Preimplantation Genetic Diagnosis (PGD) to Ensure a Matched Sibling Donor for Hematopoietic Stem Cell Transplantation (HSCT)
  • 2019 Session | George R. Buchanan Lectureship Award Presentation
  • 2019 Session | 2019 St. Baldrick’s Foundation Robert J. Arceci Innovation Award Announcement and Past Recipient Presentation
  • 2019 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship Announcement and Frank A. Oski Memorial Lectureship Award Presentation
  • 2019 Session | New Paradigms for Severe Aplastic Anemia: Genetic Screening, Eltrombopag, and Up Front Unrelated Donor BMT
  • 2019 Session | Not Too Young for That Cancer: Adolescent and Young Adult Carcinomas
  • 2019 Session | Transforming the Treatment of Chronic Pain
  • 2019 Session | Putting an End to End Organ Damage in Sickle Cell Disease
  • 2019 Session | Defining Pediatric MDS: A Morphologic or Molecular Diagnosis?
  • 2019 Session | The Power of One: Present Challenges in Treating Rare Diseases
  • 2019 Session | Hematological Manifestations of Immune Deficiencies and Dysregulatory Disorders: When should you look harder for underlying causes of Autoimmune Cytopenias?
  • 2019 Session | Oncofertility Programs: More Than Just Sperm Banking
  • 2019 Session | The (Financial) Cost of a "Cure"
  • 2019 Session | (2001) Potential Utility of MRD to Identify Relapse in pALL Patients Treated with Tisagenlecleucel
  • 2019 Session | (2002) Lentiglobin Gene Therapy in Transfusion-Dependent Β-Thalassemia Patients with Non-β0/β0 Genotypes
  • 2019 Session | (2003) Mechanisms of Resistance to the Type II JAK2 Inhibitor CHZ868 in B-Cell Acute Lymphoblastic Leukemia
  • 2019 Session | (2004) Discovering Noncoding Genetic Elements that Regulate Globin Synthesis
  • 2019 Session | (2005) Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis: Safety & Efficacy
  • 2019 Session | (2006) Modeling IKZF1 Lesions in B-cell Acute Lymphoblastic Leukemia Reveals Potential Therapeutic Targets
  • 2019 Session | (2007) Prognostic Determinants in Childhood T-cell Acute Lymphoblastic leukemia: Results of DFCI 05001
  • 2019 Session | (2008) Gap Junction Interference increases Apoptosis in ALL cells and augments effects of Antimetabolites
  • 2019 Session | (2009) Hydroxyurea Lowers Tricuspid Regurgitant Jet Velocity in Children with Sickle Cell Anemia
  • 2019 Session | (2010) Novel Next-Generation Sequence based Assay for Non-Invasive Prenatal Testing of Sickle Cell Disease
  • 2019 Session | (2011) Gabapentin for Pain in Sickle Cell Disease: Results of a Randomized Phase II Clinical Trial
  • 2019 Session | (2012) Quality of Life is the most important Indication for Second-Line ITP Treatment in Children
  • 2019 Session | (2013) BCL2-Inhibitor Response in Neuroblastoma: Biomarkers and Therapy Resistance
  • 2019 Session | (2014) The Clinical Application of Molecular Testing in Pediatric Solid Tumors: An Institutional Experience
  • 2019 Session | (2015) Enhancing Tumor Directed T Cells with an Interleukin-7 Signal Modulator
  • 2019 Session | (2016) Epigenome Screening Identifies Transcriptional Elongation as Therapeutic Vulnerability in DIPG
  • 2019 Session | (2017) Levofloxacin Prophylaxis
  • 2019 Session | (2018) Renal Tumors: Future Roadmap
  • 2019 Session | (2019) Soft Tissue Sarcoma
  • 2019 Session | (2020) Realizing Effectiveness across Continents with Hydroxyurea (REACH): A Prospective Multi-National Trial of Hydroxyurea for Sickle Cell Anemia in Sub-Saharan Africa
  • 2019 Session | (2021) Leucine for the Treatment of Transfusion Dependence in Patients with Diamond Blackfan Anemia
  • 2019 Session | (2022) A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds
  • 2019 Session | (2023) Peripherally Inserted Central Catheters (PICCs), the Leading Cause of Central Venous Catheter Associated Thrombosis in Children
  • 2019 Session | The Role of Survivorship Research in Advancing Childhood Cancer Care and Quality of Survival
  • 2019 Session | (2024) Septic Shock (SS) Incidence in National ALL & AML Cohorts using Administrative & Clinical Trial Data
  • 2019 Session | (2025) Nelarabine Abrogates Relapse Rates in CNS-3 T-ALL: A Report from Children’s Oncology Group AALL0434
  • 2019 Session | (2026) Current Cancer Survivorship Practices: A Report from the Children’s Oncology Group (COG)
  • 2019 Session | (2027) Intra-Arterial Chemotherapy for Retinoblastoma: A 7-year Single Institution Experience
  • 2019 Session | Advancing Discovery in Hematology: Bench to Bedside? No. Bedside to Bench to Bedside...
  • 2019 Session | (2028) The Shwachman Diamond Syndrome Registry: Hematologic Complications
  • 2019 Session | (2029) Characteristics and Outcomes of Unprovoked Venous Thromboembolism in the Pediatric Population
  • 2019 Session | (2030) Third Party VST are an effective Therapy for the Treatment of BK-Virus Reactivation after Transplant
  • 2019 Session | (2031) Inhibition of Nemo-Like Kinase improves Erythropoiesis in Models of Diamond Blackfan Anemia
  • CI SIG Webinar
  • October 2021 eNews
  • 2025 Conference App Download Instructions
  • June 2025 Advocacy Brief

eNews

August 2026

Table of Contents

  • President's Message
    • Importance of Research in PHO
  • Upcoming Programming
    • Virtual Career Fair
    • Webinar Series
    • COG
    • Review Course
  • Society News
    • Call for Awards
    • Career Path Spotlight
    • KARE
  • Membership Bulletin
    • ICDP Mentoring
    • Supporting Fellows, Residents, Medical Students
    • Get Involved in ASPHO!
    • Committee Currents: LDC/PDC
    • SIG Spotlight: Global, Hospitalist Medicine, Integrative PHO, Well-Being
  • Case Quiz
  • Conference Central
    • #ASPHO2027 in Montréal
    • Passports
    • #ASPHO2026 Highlights
    • Conference Evaluations, CME
    • MOC
  • Career Resources

President's Message

Daniel Wechsler, MD FAAP

PHO Research Matters Now More Than Ever

Full disclosure: I have been involved in basic science research for more than 45 years—starting in college, during medical/graduate school and pediatric hematology/oncology (PHO) fellowship, and throughout my faculty career. As a pediatric oncology clinician, I have participated in designing clinical trials and have enrolled numerous patients on COG studies. For decades, PHO research has led to safer, more effective treatments for our patients with cancer and blood disorders and has also driven new biological discoveries. Over the last few months, however, the future of PHO research has become less certain as a result of several converging pressures.

The national research environment is under real strain. PHO already receives a relatively small share of overall research funding, and recent policy proposals and budget pressures have threatened grant support, institutional indirect costs, and the availability of training awards. Proposed cuts to federal agencies and new rules affecting how grants are reviewed and reimbursed risk destabilizing individual research programs as well as collaborative data resources. These threats have the potential to disrupt ongoing trials—the recent dismantling of the Pediatric Brain Tumor Consortium is a glaring example—and result in losing early career investigators to other fields.

Recent training recommendations that deemphasize formal research expectations during fellowship also risk unintentionally weakening the scientific foundation of PHO. So many breakthroughs in our field originated from clinician-scientists who first engaged in research as trainees. Signaling that substantial protected time for investigation is optional rather than essential threatens the pipeline of future investigators and the culture that values inquiry. Over time, this will lead to fewer fellows pursuing research projects and less integration of translational questions into clinical care.

Early exposure to research can be formative for fellow trainees. It fosters the ability to ask good questions, interpret evidence, and understand the rationale behind current care approaches. Trainees who actively participate in research learn to think critically about experimental/trial design and analysis of outcomes. These skills make them stronger clinicians and clinical trialists. Exposure to research gives trainees perspective on the pace and complexity of discovery. Having the opportunity to see questions evolve from bedside observations to lab insights to clinical trials offers a unique perspective that emphasizes how research is ultimately about human outcomes. This exposure can reduce the intimidation associated with research and show trainees that meaningful contributions are possible at many levels. Because our specialty relies so heavily on collaboration, trainees who learn research skills early are well prepared to contribute to multi-institutional studies and cooperative group efforts.

For PHO, research is not an academic luxury. It is the foundation of better cures, fewer toxicities, and improved long-term outcomes. When certification standards no longer clearly affirm research as a core component of PHO subspecialty training, they risk reinforcing budgetary and operational decisions that divert time and resources away from discovery. It is critical that we work together to develop novel approaches to preserve and uphold the long-standing emphasis that our field has on inquiry, in spite of current prevailing pressures that are pushing us in the opposite direction.

Upcoming Programming

Advance Your Career at the Member-Only Virtual Career Fair

Connect with healthcare institutions hiring pediatric hematology/oncology professionals during this month’s ASPHO Virtual Career Fair.

This free, members-only event takes place Wednesday, August 12, 2026, 10 am–2 pm CT, offering a convenient and confidential way to meet recruiters, explore open roles, and learn more about organizations’ PHO programs.

2026–2027 ASPHO Webinar Series

Continue learning at your convenience with the 2026–2027 ASPHO Webinar Series, featuring expert-led education on timely pediatric hematology/oncology topics. The 2026–2027 ASPHO Webinar Series will launch in fall 2026. Learn more about the webinar topics featured in the 2026–2027 below.

The Education Committee is excited to announce the following topics will be featured in the 2026–2027 ASPHO Webinar Series:

  • Monday, September 28: A Day in the Life of Peds Hematology/Oncology in a Small Program: A Panel Discussion (Small Program SIG)
  • Harnessing Immunity Without Harm (Clinical Immunology SIG)
    • Monday, October 26: Part 1: The Price of Suppression:
      Immunosuppressant Toxicities and Monitoring
    • Monday, November 2: Part 2: Immune Storms and Checkpoint Pitfalls:
      Immune-Related Adverse Events of Novel Immunotherapies
  • Monday, December 7: From Burnout to Well-Being: The Role of Communication (Well-Being SIG and Advanced Practice Provider SIG)
  • Date TBA: Qualities and Benefits of Successful Hospital Based Programs (Hospitalist SIG and Advanced Practice Provider SIG)
  • Date TBA: Gene Therapy for Pediatric Sickle Cell Disease: Chronic Pain and Other Complications
  • Date TBA: Beyond the Period: Heavy Menstrual Bleeding in Adolescent and Young Adult Females (AYA SIG)

More information, including the schedule and registration details, will be announced soon. Previous webinars are available on-demand and can be accessed on the ASPHO website. Webinars are free for ASPHO members and $35 for nonmembers.

ASPHO Participates at the COG Fall Meeting

ASPHO will once again participate at the 2026 COG Fall Meeting in Chicago, IL, October 6-9. Visit us at the ASPHO booth to learn more about our webinars, mentoring programs, and Review Course and get excited about #ASPHO2027 in Montréal! Don’t forget to register and attend the ASPHO/COG Joint Session, Current Controversies in the Treatment of Children with Newly Diagnosed High-Risk Neuroblastoma, on Thursday, October 8, 10 am–12 pm.

2027 Review Course

ASPHO is excited to announce the highly acclaimed 2027 Review Course will take place January 28–31, 2027. Similar to previous courses, ASPHO will offer the Review Course in a fully virtual format in 2027.

We look forward to providing a rich meeting and learning experience offering unique and expanded opportunities for attendees to learn, network, connect, review, and study for the upcoming American Board of Pediatrics pediatric hematology/oncology subspecialty certification exam, scheduled for April 1, 2027. Review Course registration will open in October.

Society News

Call for Awards: Celebrate Colleagues Advancing PHO

One of the highlights for a pediatric hematology/oncology program is when one of its faculty is recognized on a national stage. Pediatric hematology/oncology specialists possess exceptional skills, dedication, and leadership in their daily efforts caring for children, adolescents, and young adults, and ASPHO is proud to recognize members of our community for their remarkable work.

ASPHO is the place where we can celebrate these efforts with our members and community. ASPHO's Call for Awards is currently open, and now is your chance to nominate your exceptional colleagues for the awards below.

Do you know a senior physician or other professional who’s made an impact on the subspecialty through some combination of research, education, patient care, and advocacy who would be a candidate for the Distinguished Career Award?

Do you know an accomplished educator, committed mentor, and effective speaker who would be a candidate for the George R. Buchanan Lectureship Award?

Do you know a mid-career childhood cancer survivorship investigator who has demonstrated their commitment to this segment of the population who would be a candidate for the Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship?

Do you know an outstanding clinical or laboratory investigator with cutting-edge research who would be a candidate for the Frank A. Oski Memorial Research Lectureship Award? For the second year, through the generous support of Hyundai Hope on Wheels, the Oski Research Lectureship Award provides a $15,000 honorarium and travel expenses to the 2026 ASPHO Conference.

Submit your nomination—or for the Northwestern Mutual Award, your application—by Thursday, September 24, 2026, to be recognized in Montréal at the 2027 ASPHO Conference, May 11–14.

Abstracts and Awards Call: Save the Date—Share Your Expertise at #ASPHO2027

The Call for Abstracts for the 2027 ASPHO Conference, May 11–14, 2027, in Montréal, Québec, Canada, will open in October and will close on Monday, December 21, 3 pm CT. Look for information this fall on how to submit an abstract for papers and posters for presentation at the 2027 ASPHO Conference. Applications for the Young Investigator Award and for the Early Career and Advanced Practice Provider Travel Stipend Awards will also be accepted with abstract submissions and are also due Monday, December 21, 3pm CT. For the second year, through the generous support of Hyundai Hope on Wheels, up to $2,000 of travel support and complimentary conference registration will be awarded to up to six individuals for the Early Career and Advanced Practice Provider Travel Stipend awards. A call for late-breaking abstracts will open in January.

Career Path Spotlight

ASPHO is pleased to present this month’s edition of the Career Path Spotlight series. This resource showcases the career paths of a variety of ASPHO physician members and informs medical students, residents, pediatric hematology/oncology fellows, and early career junior faculty members of the career opportunities available to them.

This month’s spotlight features Dr. Andrea Gross from Cincinnati Children’s Hospital in Cincinnati, OH.

Save 20% as You Strengthen Your PHO Knowledge with KARE Resources

Advance your pediatric hematology/oncology knowledge with ASPHO’s 2025 KARE Toolkit resources, designed for flexible, self-paced review of key subspecialty content. Save 20% on individual purchases or consider an institutional group discount to support your team.

The KARE: Knowledge Assessment Resource features more than 500 interactive self-assessment questions with expert-developed rationales across 35 topic areas, while the PHO Review Course On Demand includes 35 recorded lectures from the 2025 ASPHO Review Course. Save 20% on KARE Toolkit resources as you strengthen your PHO expertise and stay current in the field. Purchase each resource individually or maximize learning and savings with the KARE Plus set, which combines both products and offers opportunities to earn CME and MOC Part 2 credit while supporting MOCA-Peds and ABP initial certification exam preparation.

Membership Bulletin

Individualized Career Development Program 2027–2028 Class: Call for Applications Opens in September!

The call for mentee applications for our 2027–2028 Individualized Career Development Program class will open in mid to late September. This program from the Professional Development Committee is designed to help midcareer members navigate the unique opportunities and challenges of this career stage, providing external guidance and support in their career development.

Learn more about the member opportunity, and what past participants say about their experience below.

Midcareer ASPHO members who completed PHO fellowship between 2011 and 2018 (8 to 15 years post PHO fellowship graduation) will be considered for the 2027–2028 class. To learn more about the program, visit ASPHO’s mentoring webpage. When the call for applications opens, a link to the application will be made available on the webpage. Members who are eligible for selection into the program will receive email communications noting the call opening as we get closer to the date.

Following application review, up to 10 mentees will be selected for the 2027–2028 program class, which will launch with an in-person meeting at the 2027 ASPHO Conference in Montréal. Mentee applicants will be notified of their selection status by early winter.

Hear what some of our previous program mentees had to say about their experience with the Individualized Career Development Program:

“The program has been one of the most impactful mentoring relationships of my career. The wisdom of a strong mentor from outside of my institution has made me a better leader, researcher, and clinician.”

“The program was so helpful—the structure and roadmap for the mentored relationship made the process seamless and so user friendly. Given how busy everyone is, having a pathway with a clear on-ramp for finding a new mentor that is external to my institution was so valuable and made the process so time efficient.”

Supporting Fellows, Residents, Medical Students

ASPHO welcomes our newest early career members who are embarking on their careers in pediatric hematology/oncology and encourages you to get involved with the ASPHO community and programs.

Support your career path with the abundant networking, education, and professional development opportunities and resources available to ASPHO members, including

  • a community of peers and thought leaders
  • clinical advice through the online member community
  • Early Career Mentoring Program
  • opportunities to develop leadership skills
  • special savings on programs and resources
  • exclusive updates on health policy and advocacy, workforce, practice and quality, and other key developments in the field
  • access to 16 SIGs for specialized knowledge and collaboration.

ASPHO is proud to be alongside you as you pursue your career goals and new endeavors. Learn more about your member benefits designed to support your journey and explore ways to get involved with the Society. Strengthen your institution’s care team with the group trainee membership application.

Get More Involved With Your PHO Community

Make the most of your ASPHO membership by exploring ways to connect, learn, and contribute through the Member Engagement webpage.

Members can join the Member Community, participate in Special Interest Groups, engage in the Clinical Forum, explore volunteer opportunities, access education and advocacy resources, and stay connected through ASPHO publications and social media. ASPHO also offers meaningful opportunities to support the next generation of pediatric hematology/oncology professionals by encouraging fellows, residents, and medical students to get involved, build connections, and discover resources that can help them grow within the subspecialty. Learn More.

Committee Currents: Leadership Development and Professional Development Committees

Volunteer committees support membership and the profession with projects based on committee charges that align with the Society’s strategic plan.

Growing Leaders Through Engagement: Opportunities Within ASPHO

ASPHO’s Leadership Development and Professional Development Committees share a common goal: to strengthen the future of pediatric hematology/oncology by intentionally developing the next generation of leaders. Central to this effort is creating meaningful, accessible pathways for members to engage through volunteer service and expanding leadership development through multiple programs and channels across the Society.

Volunteer roles within ASPHO—on committees, task forces, and short-term projects—are more than service contributions; they are structured development opportunities. The committees are working in parallel to broaden leadership development offerings through workshops, conference programming, virtual sessions, and targeted initiatives that meet members at different career stages. Together, these experiences provide a continuum of leadership growth, from entry-level engagement to advanced leadership preparation.

These opportunities are grounded in a defined set of leadership competencies reinforced through active participation. Members develop effective communication by participating in discussions and translating complex issues for varied audiences and inclusivity by ensuring diverse perspectives are incorporated into decision-making. Accountability and follow-through are strengthened through active participation and meeting deliverables and timelines. Volunteers also cultivate adaptability in dynamic environments and influence and collaboration by building consensus and working across specialties and stakeholder groups.

Members interested in volunteering can explore opportunities through the ASPHO website. The online volunteer interest form, available year-round, enables individuals to share their expertise, interests, and prior experience, helping align placements with both Society needs and personal development goals.

Most ASPHO committee appointments are structured as 2-year terms, offering continuity and the opportunity to take on increasing responsibility over time. ASPHO is committed to cultivating an engaged, diverse leadership pipeline, and we intentionally look to active volunteers when identifying future chairs, board members, and other leaders.

Volunteer engagement remains one of the most meaningful ways to grow as a leader within ASPHO while contributing to the strength and sustainability of our community.

SIG Spotlight: Hospitalist Medicine, Integrative PHO, Well-Being

Members are the engine of ASPHO’s Special Interest Groups (SIGs), in which common interests and challenges drive discussion to spur solutions, learning, and collaboration. In this issue of eNews, read about activities and issues being addressed by the Hospitalist Medicine, Integrative PHO, and Well-Being SIGs.

Hospitalists Medicine

The Hospitalist Medicine SIG was formed in 2022 and continues to grow as a national community of clinicians dedicated to advancing hospital-based pediatric hematology/oncology care. The SIG provides a forum for clinicians interested in hospital-based PHO care to connect, exchange ideas, and learn from one another while strengthening a growing community committed to advancing hospital-based pediatric hematology/oncology care.

Our monthly meetings bring together members from diverse practice settings to discuss hospitalist programs across the country, share challenges and successes, and explore innovative approaches to inpatient care. Topics include inpatient coverage models, clinical operations, workforce development, quality improvement, medical education, and the many roles hospitalists play in delivering high-quality care. Beyond discussion, the SIG serves as a catalyst for multi-institutional collaboration, generating scholarly work, practical resources, and implementation approaches that help define best practices and advance the evolving role of hospitalists within pediatric hematology/oncology.

Recognizing that not all providers engaged in this work have the title of “hospitalist,” the SIG welcomes any ASPHO member interested in improving hospital-based pediatric hematology/oncology care. Whether you are launching a new hospitalist program, refining an established service, or looking to learn from colleagues across the country, the SIG offers opportunities to exchange ideas, contribute to collaborative initiatives, and help shape best practices in hospital-based pediatric hematology/oncology care.

Interested in joining the Hospitalist SIG? Join the Hospitalist and other SIGS by updating your member profile. mailto: This email address is being protected from spambots. You need JavaScript enabled to view it.

Integrative PHO

The Integrative Pediatric Hematology Oncology (Integrative PHO) SIG is a dynamic community of over 180 members dedicated to advancing evidence-based integrative approaches that improve quality of life for children with cancer and blood disorders. Our members include clinicians, researchers, and allied health professionals who are passionate about incorporating therapies such as nutrition, physical activity, mind-body practices, and the arts into conventional care.

A recent focus of our SIG is optimizing approaches to diet and exercise as essential components of supportive care. We recently conducted a survey of ASPHO members on current practices regarding nutrition and physical activity in pediatric oncology, with results currently being prepared for publication. At the 2024 ASPHO Annual Meeting, we hosted a well-received workshop, “Physical Activity Guidelines for Children with Cancer—Time to Make a Move.” Looking ahead, we hope to launch a multicenter trial exploring mind-body interventions.

IWe also host educational events, including our recent ASPHO webinar, “Mediators and Moderators of Active Music Engagement to Reduce Traumatic Stress in Parents of Young Children with Cancer.” We are currently working to organize a workshop on how to build an integrative program for pediatric oncology patients.

The Integrative PHO SIG provides a welcoming space for collaboration, learning, and innovation. Whether you're new to integrative medicine or experienced in the field, we invite you to join us in transforming care for children and families.

Well-Being

August is National Wellness Month, a time to recognize and celebrate the well-being of ASPHO members and the broader pediatric hematology/oncology community. Taking 1 minute out of your day to identify a positive or “good thing” can increase feelings of happiness after only 1 week!

The ASPHO Well-Being SIG is committed to fostering ongoing conversations and action steps to help you achieve personal and professional wellness. Over the past year, we conducted a survey and discovered the following among ASPHO respondents:

  • 67.2% experienced burnout in the past month
  • 77.6% reported putting off their own health care because of time pressure

Proactively addressing these issues is essential to mitigate these risks, improve our well-being, and support our colleagues and patients. We are acting by collaborating with other SIGs to cohost the 2026–2027 ASPHO Webinar Series webinar “From Burnout to Well-Being: The Role of Communication.”

We invite you to check out our Resource Library and encourage all ASPHO members to

  • join the Well-Being SIG
  • participate in our Zoom meeting on August 24th (1 pm CT) to collaborate on webinars, workshops, and other initiatives.

Together, we can strengthen our support network and promote wellness across our field.

Learn about SIG communities and visit your member account to get involved with a new SIG!

Case Quiz

case quizA 13 Year Old With Anemia

A 13-year-old female is seen in the pediatrician’s office for a routine health maintenance visit. She is overall healthy with no significant past medical history. During review of systems, she notes intermittent lightheadedness and shortness of breath with more intense physical activity over the past few weeks.

The exam is significant for mild conjunctival pallor. Her heart rate and blood pressure are normal. The remainder of the exam unremarkable.

Basic lab work is obtained. CBC results with WBC 6.9, Hgb 9.3,MCV 71, platelets 414, ANC 3.8, and absolute reticulocyte count (ARC) 42.5.

Based on the available history and physical exam, what would be the next best test to obtain?

Take the quiz.

Alison Konopka, MD, & Mahvish Rahim, MD
Division of Pediatric Hematology, Oncology, & Cellular Therapy
The Children's Hospital at Montefiore
Bronx, NY

Conference Central

#ASPHO2027 in Montréal

Experience the energy of #ASPHO2027 in Montréal, Québec, Canada, a welcoming international destination known for its historic charm, vibrant arts and culture, and distinguished culinary scene. Mark your calendar for May 11–14, and note that the conference begins on Tuesday and concludes on Friday.

Join the pediatric hematology/oncology community in a city that offers an inspiring setting to learn, connect, and explore, whether you are gathering with colleagues, discovering Montréal’s neighborhoods, or enjoying everything this memorable city has to offer.

Start Planning Your Trip for #ASPHO2027

Start planning now for the 2027 ASPHO Conference, taking place Tuesday, May 11, through Friday, May 14, 2027, in Montréal, Québec, Canada. As you look forward to joining the pediatric hematology/oncology community in this vibrant international host city, be sure to check your passport status early and allow plenty of time for any needed renewals or updates before traveling to Canada.

2026 ASPHO Conference Evaluations & Continuing Medical Education (CME) Credit

If you attended the 2026 ASPHO Conference (in-person or on-demand), complete your evaluation and claim CME credit by August 31. To claim your CME credit, visit My Library and log in with your ASPHO username and password. Then, click on the graduation cap icon next to the 2026 ASPHO Conference to access the evaluation and obtain your CME certificate. In-person attendees can also view and evaluate additional sessions on-demand and claim additional CME credit. CME credit is also available for those who registered and attended the PTCTC Educational Program that was held in conjunction with the ASPHO Conference on Tuesday, April 28.

Maintenance of Certification

Conference attendees can obtain 10 Maintenance of Certification (MOC) Part 2 points by purchasing the 2026 Online MOC Post-Test for $60 by calling ASPHO Member Services at 847.375.4716 or emailing This email address is being protected from spambots. You need JavaScript enabled to view it. . If you already purchased the 2026 MOC Post-Test, log in to your My Library with your ASPHO username and password, then click on the graduation cap next to 2026 Maintenance of Certification Conference Post-Test to access the test questions.

Career Resources

Looking to advance your career or explore fresh professional possibilities? Join next month’s Virtual Career Fair and benefit year-round in the online ASPHO Career Center.

ASPHO is pleased to offer members two Virtual Career Fairs in 2026—Wednesday, August 12, and Wednesday, November 11, 10 am–2 pm CT. The Virtual Career Fairs are your gateway to new opportunities in pediatric hematology/oncology.

Take advantage of ASPHO's Career Center and find the latest openings and opportunities in pediatric hematology/oncology. Access resumé writing assistance, coaching, reference checks, search strategy videos, and more in the Resources section. View the Career Center job board, the go-to source for institutions to post jobs and recruitment opportunities in the field. Create a personal account to save job postings, and skim FAQs for tips on navigating the site so you don’t miss out on any helpful resources.

Stay Informed of #ASPHOAdvocacy!

Have you seen the latest issue of Advocacy Brief?Learn about important legislative and regulatory issues impacting PHO; #ASPHOadvocacy efforts to support members, patients, and the profession; and how to contact your legislators to support PHO.

August2026_eNews_Kamada_MediumRectangle
  • Products
    • KARE Toolkit: Knowledge and Assessment Resources
    • Webinars
    • ASPHOcast
    • Alexion Recording
    • 2024 Compensation Survey
    • Webinar Toolkit
    • Compensation and Benefits Report
    • View the Compensation and Benefits Survey Report
    • Compensation Tool
    • Case Quizzes
  • Pediatric Blood & Cancer
    • Access Journal
    • Online Access Instructions
  • ASPHO eNews
    • August 2015 Enews
    • June 2015 Enews
    • April 2015 Enews
    • February 2015 Enews
    • December 2014 Enews
    • October 2014 Enews
    • August 2014 Enews
    • June 2014 Enews
    • April 2014 Enews
    • February 2014 Enews
    • December 2013 Enews
    • October 2013 Enews
    • August 2013 Enews
    • June 2013 Enews
    • April 2013 Enews
    • February 2013 Enews
    • October 2014 Enews
    • October 2015 Enews
    • December 2015 Enews
    • February 2016 Enews
    • April 2016 Enews
    • June 2016 Enews
    • August 2016 Enews
    • October 2016 Enews
    • December 2016 Enews
    • February 2017 Enews
    • April 2017 Enews
    • June 2017 Enews
    • August 2017 Enews
    • October 2017 Enews
    • December 2017 Enews
    • February 2018 Enews
    • April 2018 Enews
    • June 2018 Enews
    • August 2018 eNews
    • October 2018 eNews
    • February 2019 eNews
    • Member Insights: eNews 2018 Highlights
    • April 2019 eNews
    • June 2019 eNews
    • August 2019 eNews
    • October 2019 eNews
    • December 2019 eNews
    • February 2020 eNews
    • April 2020 eNews
    • June 2020 eNews
    • August 2020 eNews
    • October 2020 eNews
    • December 2020 eNews
    • April 2021 eNews
    • June 2021 eNews
    • August 2021 eNews
    • December 2021 eNews
    • February 2022 eNews
    • April 2022 eNews
    • June 2022 eNews
    • August 2022 eNews
    • October 2022 eNews
    • December 2022 eNews
    • February 2023 eNews
    • April 2023 eNews
    • June 2023 eNews
    • October 2023 eNews
    • December 2023 eNews
    • February 2024 eNews
    • March 2024 eNews
    • April 2024 eNews
    • June 2024 eNews
    • August 2024 eNews
    • October 2024 eNews
    • December 2024 eNews
    • February 2025 eNews
    • April 2025 eNews
    • June 2025 eNews
    • August 2025 eNews
    • October 2025 eNews
    • December 2025 eNews
    • February 2026 eNews
    • April 2026 eNews
    • June 2026 eNews
    • August 2026 eNews
  • Pediatric Blood & Cancer - Call for Applications for Deputy Editor
  • Practice and Quality
    • Choosing Wisely®
    • Position Paper
    • Endorsements
    • ASPHO Endorsements member only
  • Health Policy & Advocacy
    • 2016 August Advocacy Brief
    • 2016 December Advocacy Brief
    • 2017 February Advocacy Brief
    • 2017 May Advocacy Brief
    • 2017 September Advocacy Brief
    • 2017 November Advocacy Brief
    • 2018 Advocacy Brief - March
    • Contact Your Members of Congress
    • 2018-Advocacy-Brief-June
    • 2018-Advocacy-Brief-September
    • Advocacy Brief December 2018
    • 2019 Advocacy Brief - March
    • March 2019 Advocacy Brief
    • June 2019 Advocacy Brief
    • September 2019 Advocacy Brief
    • March 2020 Advocacy Brief
    • June 2020 Advocacy Brief
    • September 2020 Advocacy Brief
    • December 2020 Advocacy Brief
    • June 2021 Advocacy Brief
    • September 2021 Advocacy Brief
    • March 2022 Advocacy Brief
    • June 2022 Advocacy Brief
    • September 2022 Advocacy Brief
    • March 2024 Advocacy Brief
    • September 2024 Advocacy Brief
    • December 2024 Advocacy Brief
    • March 2025 Advocacy Brief
    • 2025 September Advocacy Brief
    • December 2025 Advocacy Brief
    • March 2026 Advocacy Brief
    • June 2026 Advocacy Brief
  • News Briefs
Advertising, Exhibits, & Support | Career Center | Calendar | Contact Us
Terms of Use & Privacy Policy » © The American Society of Pediatric Hematology/Oncology®